Journal URL: http://www.bentham.org/ctmc/index.htmPeptidomimitism is applied to the medicinal chemistry in order to synthesize drugs that devoid of the disadvantages of peptides. AT1 antagonists constitute a new generation of drugs for the treatment of hypertension designed and synthesized to mimic the C-terminal segment of Angiotensin II and to block its binding action on AT1 receptor. An effort was made to understand the molecular basis of hypertension by studying the conformational analysis of Ang II and its derivatives as well as the AT1 antagonists belonging to SARTANs class of molecules. Such studies offer the possibility to reveal the stereoelectronic factors responsible for bioactivity of AT1 antagonists and to design and synthesize...
The aim of study was to find potential antihypertensive and cardiotropic drugs among new 4-aryl-N-(a...
The renin-angiotensin-aldosterone-system (RAAS) control blood-pressure regulation, exerted by the ma...
Background: The commercially available synthetic angiotensin-I-converting enzyme (ACE) inhibitors ar...
The angiotensin II (Ang II) type 1 and type 2 receptors (AT1R and AT2R) orchestrate an array of biol...
As a continuing effort to establish the structure-activity relationships (SARs) within the series of...
This study addresses the issue of how to convert peptides into drug-like non-peptides while retainin...
As a continuing effort to establish the structure-activity relationships (SARs) within the series of...
Through the use of protein visualization software, such as Jmol, it is possible to design and ultima...
Novel AT1 receptor antagonists bearing substituted 4-phenylquinoline moieties instead of theclassica...
© 2012 Dr. Marilena A. GiarrussoHypertension is a severe condition that affects many people worldwid...
AT1 antagonists is the most recent drug class of molecules against hypertension and they mediate the...
Research about the angiotensin AT2 receptor (AT2R) has been hampered in the past by the lack of a sp...
Blood pressure regulation through the renin-angiotensin system (RAS) is mediated through the activat...
Important information on the bioactive conformation of biologically active peptides may be obtained ...
Angiotensin II receptor antagonists (ATIIRA) has become an attractive molecular target for drugs tha...
The aim of study was to find potential antihypertensive and cardiotropic drugs among new 4-aryl-N-(a...
The renin-angiotensin-aldosterone-system (RAAS) control blood-pressure regulation, exerted by the ma...
Background: The commercially available synthetic angiotensin-I-converting enzyme (ACE) inhibitors ar...
The angiotensin II (Ang II) type 1 and type 2 receptors (AT1R and AT2R) orchestrate an array of biol...
As a continuing effort to establish the structure-activity relationships (SARs) within the series of...
This study addresses the issue of how to convert peptides into drug-like non-peptides while retainin...
As a continuing effort to establish the structure-activity relationships (SARs) within the series of...
Through the use of protein visualization software, such as Jmol, it is possible to design and ultima...
Novel AT1 receptor antagonists bearing substituted 4-phenylquinoline moieties instead of theclassica...
© 2012 Dr. Marilena A. GiarrussoHypertension is a severe condition that affects many people worldwid...
AT1 antagonists is the most recent drug class of molecules against hypertension and they mediate the...
Research about the angiotensin AT2 receptor (AT2R) has been hampered in the past by the lack of a sp...
Blood pressure regulation through the renin-angiotensin system (RAS) is mediated through the activat...
Important information on the bioactive conformation of biologically active peptides may be obtained ...
Angiotensin II receptor antagonists (ATIIRA) has become an attractive molecular target for drugs tha...
The aim of study was to find potential antihypertensive and cardiotropic drugs among new 4-aryl-N-(a...
The renin-angiotensin-aldosterone-system (RAAS) control blood-pressure regulation, exerted by the ma...
Background: The commercially available synthetic angiotensin-I-converting enzyme (ACE) inhibitors ar...